Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy with anticholinergic agents for airflow obstruction.

H A Boushey1

  • 1Cardiovascular Research Institute, University of California, San Francisco 94143.

Postgraduate Medical Journal
|January 1, 1987
PubMed
Summary

Long-acting inhaled anticholinergic agents offer effective relief for airflow obstruction. Combination therapy with beta-agonists can prolong bronchodilation in asthma and increase its effectiveness in chronic obstructive pulmonary disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticosteroid and long-acting ß-agonist therapy reduces epithelial goblet cell metaplasia.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation.

Mucosal immunology·2017
Same author

Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma.

The pharmacogenomics journal·2015
Same author

Predicting worsening asthma control following the common cold.

The European respiratory journal·2008
Same author

A new perspective on concepts of asthma severity and control.

The European respiratory journal·2008
Same author

Characteristics of patients with seasonal allergic rhinitis and concomitant asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2004

Area of Science:

  • Respiratory Medicine
  • Pharmacology

Background:

  • Inhaled anticholinergic agents provide localized, long-acting bronchodilation with minimal systemic toxicity.
  • Combination therapy is frequently explored for managing obstructive airway diseases.

Purpose of the Study:

  • To evaluate the efficacy of combining anticholinergic agents with other bronchodilators.
  • To assess the impact of combination therapy on bronchodilation and drug dosage in asthma and COPD.

Main Methods:

  • Review of studies investigating anticholinergic drug interactions with beta-adrenergic agents.
  • Analysis of effects on maximal bronchodilation, duration of effect, and required beta-agonist dosage.
  • Examination of anticholinergic effects on sodium cromoglycate's inhibition of bronchospasm.

Related Experiment Videos

Main Results:

  • In asthma, combination therapy prolongs bronchodilation and allows for reduced beta-agonist dosage without compromising efficacy.
  • In chronic obstructive bronchitis and emphysema, combination therapy may enhance bronchodilation compared to beta-adrenergic agents alone.
  • Anticholinergic agents potentiate the inhibitory effects of sodium cromoglycate against various bronchospastic stimuli.

Conclusions:

  • Inhaled anticholinergics are valuable additions to asthma and COPD management, particularly in combination therapies.
  • Combination therapy offers potential benefits in prolonging bronchodilation and optimizing medication dosages.
  • Anticholinergic agents play a significant role in modulating airway hyperresponsiveness.